Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Aldeyra Therapeutics Inc (NASDAQ: ALDX) was $1.89 for the day, up 33.10% from the previous closing price of $1.42. In other words, the price has increased by $33.10 from its previous closing price. On the day, 12.94 million shares were traded. ALDX stock price reached its highest trading level at $2.0 during the session, while it also had its lowest trading level at $1.38.
Ratios:
Our analysis of ALDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 12 ’24 when Machatha Stephen sold 16,041 shares for $4.74 per share. The transaction valued at 75,975 led to the insider holds 236,771 shares of the business.
Greenberg Bruce sold 10,834 shares of ALDX for $51,313 on Aug 12 ’24. The insider now owns 126,382 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the Officer of the company, bought 10,834 shares for $5.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 112849440 and an Enterprise Value of 27001088.
Stock Price History:
The Beta on a monthly basis for ALDX is 1.11, which has changed by -0.5684931 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -68.35%, while the 200-Day Moving Average is calculated to be -63.26%.
Shares Statistics:
ALDX traded an average of 976.99K shares per day over the past three months and 4737830 shares per day over the past ten days. A total of 59.65M shares are outstanding, with a floating share count of 57.98M. Insiders hold about 2.90% of the company’s shares, while institutions hold 62.88% stake in the company. Shares short for ALDX as of 1741910400 were 3993259 with a Short Ratio of 4.09, compared to 1739491200 on 3677624. Therefore, it implies a Short% of Shares Outstanding of 3993259 and a Short% of Float of 8.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Aldeyra Therapeutics Inc (ALDX) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.29, with high estimates of $2.48 and low estimates of -$0.33.
Analysts are recommending an EPS of between $1.52 and -$1.32 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.23, with 4.0 analysts recommending between $0.61 and -$0.58.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $48.91M in the next fiscal year. The high estimate is $137.52M and the low estimate is $13M.
